The RCP got this right: Promotion of tobacco harm reduction is playing right into the tobacco industry’s hands

I previously published three detailed critiques of the 2024 UK Royal College of Physicians report E-cigarettes and Harm Reduction: An Evidence Review for being an incomplete and selective review of the literature in three areas — underestimating the magnitude of disease risk caused by e-cigarettes, ignoring the large body of real world evidence that e-cigarettesContinue reading “The RCP got this right: Promotion of tobacco harm reduction is playing right into the tobacco industry’s hands”

Calif updates state ban on sales of flavored tobacco products to close loophole and strengthen enforcement: A great model for others

When California passed its law prohibiting the sale of flavored tobacco products in 2020, including menthol cigarettes, RJR and other tobacco interests forced a referendum to try and block the law. Voters upheld the law in 2022, and it went into effect. This law prohibited retail sales of tobacco products with a “characterizing flavor,” looselyContinue reading “Calif updates state ban on sales of flavored tobacco products to close loophole and strengthen enforcement: A great model for others”

Register for free UCSF indusry documents workshop Oct 8

Registration is now open for the UCSF Annual Tobacco and Other Industry Documents Workshop. The workshop, which is a joint project of UCSF’s Center for Tobacco Control Research and Education and the UCSF Library will again be held virtually on October 8th from 9am-12:15pm Pacific Time. Participants will gain comprehensive knowledge of UCSF’s Industry DocumentsContinue reading “Register for free UCSF indusry documents workshop Oct 8”

FDA should deny renewal of PMI’s modified risk claim for Swedish Match Snus because of joint marketing with ZYN nicotine pouches

My UCSF colleagues and I submitted this public comment to FDA. It is an updated version of the one we submitted to TPSAC on June 20, 2024. A PDF is here. The Regulations.gov tracking number is lz3-50m7-es1x. FDA should consider the significant public health issues, especially for youth, created by Philip Morris International’s co-marketing ofContinue reading “FDA should deny renewal of PMI’s modified risk claim for Swedish Match Snus because of joint marketing with ZYN nicotine pouches”

FDA should not renew permission for PMI Swedish Match snus to make modified risk claims

My UCSF colleagues and I submitted this public comment to FDA last week opposing renewal of its marketing order allowing PMI’s Swedish Match Snus to make modified risk claims. (This is an updated version of the comment we submitted to TPSAC on June 10, 2024. I was backpacking when the comment was actually submitted, henceContinue reading “FDA should not renew permission for PMI Swedish Match snus to make modified risk claims”

Tobacco free generation is a bad idea that should be abandoned

In the last few years the idea of a free generation in which tobacco sales would be prohibited to all people born after a certain date has gained some traction. Ever since the idea was first proposed by some Singapore researchers in 2010, I have thought it was a bad idea. Other than declining toContinue reading “Tobacco free generation is a bad idea that should be abandoned”

FDA should consider the significant public health issues, especially for youth, created by PMI co-marketing of its Swedish Match General Snus and ZYN oral nicotine products and not reauthorize modified risk claims for General Snus

My colleagues at UCSF and I submitted this comment to the FDA Tobacco Products Scientific Advisory Committee opposing extension of PMI’s current authorization to make modified risk claims because its co-marketing with its ZYN nicotine pouch is fundamentally misleading. TPSAC is holding a meeting to discuss the modified risk request on June 26, 2024. AContinue reading “FDA should consider the significant public health issues, especially for youth, created by PMI co-marketing of its Swedish Match General Snus and ZYN oral nicotine products and not reauthorize modified risk claims for General Snus”